Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Graham J. Durant is active.

Publication


Featured researches published by Graham J. Durant.


Tetrahedron-asymmetry | 2000

Asymmetric synthesis of a neuroprotective and orally active N-methyl-d-aspartate receptor ion-channel blocker, CNS 5788

Seetharamaiyer Padmanabhan; Ruth C. Lavin; Graham J. Durant

Abstract Asymmetric synthesis of N -(2-chloro-5-methylthiophenyl)- N′ -(3-methylsulfinylphenyl)- N′ -methylguanidine (CNS 5788) was achieved in high enantiomeric excess through condensation of the cyanamide derivative, 6 and the sulfinylaniline hydrochloride, 5 . The key step involved the asymmetric oxidation of N -methyl-3-methylthioaniline using a Davis reagent.


Bioorganic & Medicinal Chemistry | 1996

Synthesis and biochemical activity of novel amidine derivatives as m1 muscarinic receptor agonists

Babatunde Ojo; Philip G. Dunbar; Graham J. Durant; Peter I. Nagy; James J. Huzl; Sumudra Periyasamy; Dan O. Ngur; Afif A. El-Assadi; Wayne Hoss; William S. Messer

As part of a continuing effort aimed at the development of selective, efficacious, and centrally active m1 muscarinic agonists for the treatment of Alzheimers disease, a series of amide and hydrazide amidine derivatives (2a-e and 3b-d) was synthesized and examined for muscarinic agonist activity. Preliminary biochemical studies indicated that 2b, 2d, and 3d bound to muscarinic receptors in rat brain and stimulated phosphoinositide (PI) metabolism in rat cerebral cortex. Compounds 2b and 2d were also highly efficacious at m1 muscarinic receptors expressed in cultured A9 L cells. Molecular modeling studies suggest slightly different modes of interaction with m1 receptors for the ester and amide derivatives. Also, hydrogen-bond formation with a Thr residue may be important for m1 muscarinic agonist potency. The data suggest that the amide moiety can replace the ester group found in muscarinic agonists and provide further support for the utility of amidine derivatives in the development of efficacious m1 agonists.


Synthetic Communications | 1997

A Convenient One Pot Procedure for N-Methylation of Aromatic Amines Using Trimethyl Orthoformate

Seetharamaiyer Padmanabhan; N. Laxma Reddy; Graham J. Durant

Abstract Aromatic amines react with trimethyl orthoformate in the presence of concentrated sulfuric acid followed by acid hydrolysis to afford mono methylated amines in moderate to good yields.


Bioorganic & Medicinal Chemistry Letters | 1992

Synthesis, biochemical activity and behavioral effects of a series of 1,4,5,6-tetrahydropyrimidines as novel ligands for M1 receptors

William S. Messer; Philip G. Dunbar; Taikyun Rho; Sumudra Periyasamy; Dan O. Ngur; Brenda R. Ellerbrock; Mark Bohnett; Kevin Ryan; Graham J. Durant; Wayne Hoss

Abstract A series of novel tetrahydropyrimidines was synthesized and examined for M 1 muscarinic receptor activity. 1,4,5,6-Tetrahydro-5-methoxycarbonyl-pyrimidine hydrobromide ( 1a ; CDD-0034-C) displayed a high affinity for muscarinic receptors in rat brain and stimulated PI metabolism in rat hippocampus. Compound 1a ameliorated memory deficits associated with lesions of the septohippocampal cholinergic system in rats.


Journal of the American Chemical Society | 1993

Theoretical studies on hydration of pyrrole, imidazole, and protonated imidazole in the gas phase and aqueous solution

Peter I. Nagy; Graham J. Durant; Douglas A. Smith


Archive | 1993

4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3-receptor antagonists and therapeutic uses thereof

Graham J. Durant; Amin Mohammed Khan


Annals of the New York Academy of Sciences | 1995

Neuroprotective Use‐Dependent Blockers of Na+ and Ca2+ Channels Controlling Presynaptic Release of Glutamatea

Stanley M. Goldin; Katragadda Subbarao; Rahul Sharma; Andrew Gannett Knapp; James B. Fischer; Deborah Daly; Graham J. Durant; N. Laxma Reddy; Lain-Yen Hu; Sharad Magar; Michael E. Perlman; Jun Chen; Steven H. Graham; William F. Holt; David J. Berlove; Lee David Margolin


Archive | 1993

Preparation of substituted guanidines

Graham J. Durant; Sharad Magar


Archive | 1994

Histamine H3 -receptor antagonists and therapeutic uses thereof

Graham J. Durant; Amin Mohammed Khan; Clark E. Tedford


Archive | 1993

Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists

Graham J. Durant; Amin Mohammed Khan

Collaboration


Dive into the Graham J. Durant's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge